April 9, 2018
Temple Daily Telegram|By Janice Gibbs
A new tenant of the district, Advance Scanner, recently won first prize, $75,000, in the Epilepsy Foundation’s Shark Tank Competition. Advance Scanner also won an additional $75,000 as audience favorite.
The award was reported at the Temple Health and Bioscience District monthly board meeting.
Advanced Scanners use proprietary scanner technology to improve visualization and data for surgeons during surgery.
Their project is a 3D Machine Vision System for Surgical Navigation of the Human Brain.
“We make bionic eyes for brain surgeons,” Levine said. “The reason that’s valuable is that during open brain surgery the brain changes shape.”
The surgical navigation system uses a static MRI, he said.
“We built a device that looks at the exposed brain during surgery and tracks sub millimeter changes to the brain’s surface and intuits how that affects the rest of the brain,” Levine said. “The eye will animate the MRI so it stays accurate.”
The Epilepsy Therapy Project, an initiative of the Epilepsy Foundation, invites entries that represent the most innovative new ideas in epilepsy treatment and care for its annual Shark Tank Competition. The winners of the 2018 Shark Tank Competition competed for awards to support the development and commercialization of an important new product, technology, or therapeutic concept to help people with epilepsy.
Advance Scanner was accepted as a startup in a cohort within the MassChallenge accelerator program in Boston.
MassChallenge is a nonprofit organization that helps startups succeed without taking equity. Around since 2010, the accelerator has helped 1,211 startups.
SiMMo3D, a Bioscience District placed fourth in the “Elevate My Business” pitch contest at Capital Factory in Austin. This was part of a 12-week accelerator boot camp.
SiMM03D, co-founded by Ryan Quinn and Colin Dodson, is dedicated to developing synthetic organ models for training surgeons, biomedical research and teaching medical students.
The company has established a partnership with Arsenal Products, a biomedical device manufacturer. Through partnerships, SiMMo3D has achieved milestones that were planned for the end of 2018, according to Tami Annable, executive director of the Temple Health and Bioscience District.
Cage Biotech is a potential tenant. The group is in the preclinical research phase of a therapeutic drug to treat ovarian cancer.
“This will be our first company that will use the tissue culture room,” Annable said. “They are looking to have interns.”
Association of University Tech Mangers was held in Phoenix in February and next year will be in Austin.
“I’d like to get a tour together and bring up as many of these tech transfer managers to see our facility,” she said.
There have been a number of tours of the facility in February and March, including Bobby Ott, Denise Ayers and Amy Contrucci who are interested in setting up two internships per year. The students would work 15 hours per week and the district would have to come up with the salaries.
“SiMMo3D is interested in the internships,” Annable said.
The Lunch and Learn Webinar about the NIH was held March 27. Eleven people attended, physicians from Baylor Scott & White and Ph.D.s from Texas A&M.
Thomas Baird, president of the Bioscience District Board, suggested recording the Webinars and setting up a YouTube channel that people can open the link and watch.
The district’s symposium, Growing Your Startup From the Ground Up, will be held May 4.
The conference features a wealth of notable, experienced speakers in the medical technology, medical device, biotechnology and health technology spaces who work with startups and investors. From protecting ideas, to locating funding resources, to making a profit, the topics and panels will walk through every step of a startup’s journey from conception to commercialization. In addition, the event offers multiple opportunities to network with key industry contacts.
Ten individuals will have an opportunity to pitch their early stage start ups at the symposium.